Press releases

Press releases | May 21, 2016

Inmedix to Discuss Breakthrough Fast/Fail Development for Autoimmune Disease Therapeutics at 2016 Life Science Innovation Northwest

Seattle, WA- May 18, 2016--Inmedix (, a medical diagnostic company combining brain and immunology research to determine treatment outcomes and predictors for rheumatoid arthritis and other autoimmune diseases, today announced that CEO Andrew Holman, MD, will be a podium presenter at 2016 Life Science Innovation Northwest (LSINW), being held June 1-2, 2016 at the Washington State Convention Center.

Click below to read the full press release.